Metabolic syndrome is an independent predictor of fibrosis progression in patients with recurrent hepatitis C (HCV) after liver transplantation (LT) using serial biopsy specimens

被引:0
|
作者
Hanouneh, Ibrahim A. [1 ]
Miller, Charles M. [1 ]
McCullough, ArthurJ. [1 ]
Lopez, Rocio [1 ]
Aucejo, Federico [1 ]
Feldstein, Ariel E. [1 ]
Zein, Nizar N. [1 ]
机构
[1] Cleveland Clin, Transplant Ctr, Cleveland, OH 44106 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
530
引用
收藏
页码:473A / 473A
页数:1
相关论文
共 50 条
  • [21] Fibrosis progression on protocol liver biopsies in patients with recurrent HCV following liver transplantation
    De Martin, Eleonora
    Boninsegna, Sara
    Senzolo, Marco
    Guido, Maria
    Gambata, Martina
    Germani, Giacomo
    Masier, Annalisa
    Zanus, Giacomo
    Cillo, Umberto
    Burra, Patrizia
    HEPATOLOGY, 2007, 46 (04) : 478A - 478A
  • [22] Fibrosis progression and graft loss in patients with recurrent HCV following liver transplantation (LT): The impact of allograft rejection.
    Yilmaz, N
    Shiffman, ML
    Stravitz, RT
    Sterling, RK
    Luketic, VA
    Sanyal, AJ
    Mills, AS
    Contos, MJ
    Maluf, D
    Cotterell, A
    Posner, MP
    Fisher, RA
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 574 - 574
  • [23] Histopathologic analysis of the progression to cirrhosis in patients with recurrent hepatitis C viral (HCV) infection after liver transplantation.
    Schiano, TD
    Fiel, MI
    Ye, MQ
    Min, AD
    Kim-Schluger, L
    Sheiner, PA
    Sigal, SH
    Thung, SN
    Bodenheimer, HC
    HEPATOLOGY, 1999, 30 (04) : 658A - 658A
  • [24] Determinants of hepatitis C virus (HCV) infection after liver transplantation (LT)
    Everhart, JE
    HEPATOLOGY, 1998, 28 (04) : 349A - 349A
  • [25] Angiotensin Blockade Does Not Affect Fibrosis Progression in Recurrent Hepatitis C After Liver Transplantation
    Guillaud, O.
    Gurram, K. C.
    Puglia, M.
    Lilly, L.
    Adeyi, O.
    Renner, E. L.
    Selzner, N.
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (06) : 2331 - 2336
  • [26] Successful antiviral therapy for recurrent hepatitis C after liver transplantation stops progression of fibrosis
    Selzner, Nazia
    Adeyi, Oyedele
    Lilly, Leslie
    Herath, Chaturika
    Gurrarn, Krishna
    Therapondos, George
    Kashfi, Arash
    McGilvray, Fail
    Greig, Paul
    Cattral, Mark
    Selznerl, Markus
    Guindi, Maha
    Grant, David
    Levy, Gary
    Renner, Eberhard L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 609 - 609
  • [27] Fibrosis progression in patients with recurrent chronic hepatitis C virus and occult hepatitis BCo-infection after liver transplantation
    Hui, Chee-Kin
    Lau, Eva
    Kim, Michael
    Monto, Alexander
    Luk, John M.
    Leung, Nancy
    Lo, Chung-Mau
    Fan, Sheung-Tat
    Wright, Teresa L.
    Lau, George K. K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A80 - A81
  • [28] Role of replicative senescence in the progression of fibrosis in hepatitis C virus (HCV) recurrence after liver transplantation
    Trak-Smayra, V
    Contreras, J
    Dondero, F
    Durand, F
    Dubois, S
    Sommacale, D
    Marcellin, P
    Belghiti, J
    Degott, C
    Paradis, V
    TRANSPLANTATION, 2004, 77 (11) : 1755 - 1760
  • [29] A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation
    Yilmaz, Nevin
    Shiffman, Mitchell L.
    Stravitz, R. Todd
    Sterling, Richard K.
    Luketic, Velimir A.
    Sanyal, Arun J.
    Mills, A. Scott
    Contos, Melissa J.
    Coterell, Adrian
    Maluf, Daniel
    Posner, Marc P.
    Fisher, Robert A.
    LIVER TRANSPLANTATION, 2007, 13 (07) : 975 - 983
  • [30] Patients with recurrent HCV infection and renal dysfunction after liver transplantation have slower fibrosis progression
    Cholongitas, E.
    Quaglia, A.
    Samonakis, D.
    Papatheodoridis, G. V.
    Senzolo, M.
    Triantos, C.
    Patch, D.
    Dhillon, A. P.
    Burroughs, A. K.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S58 - S59